A Study to Assess the Safety and Efficacy of Levodopa-carbidopa Intestinal Gel (LCIG) for the Treatment of Non-motor Symptoms in Patients With Advanced Parkinson's Disease

NCT01736176 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

39

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Parkinson's Disease

Interventions

DRUG: Levodopa-Carbidopa Intestinal Gel
PROCEDURE: Percutaneous Endoscopic Gastrostomy with Jejunal Extension (PEG-J)
DRUG: Levodopa-carbidopa Immediate Release (LC-IR) Tablets

Sponsor

AbbVie (prior sponsor, Abbott)